◀ Back to WNT11

AR — WNT11

Text-mined interactions from Literome

Yang et al., Oncogene 2006 (Prostatic Neoplasms) : Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells
Tycko et al., Curr Mol Med 2007 (Prostatic Neoplasms...) : Beta-catenin gain-of-function mutations are strongly linked to WT1 loss-of-function mutations in syndromic Wilms tumors, and Wnt/beta-catenin signaling increases androgen receptor mRNA expression and blocks apoptosis in prostate cancers
Thompson et al., Prostate 2010 (Neoplasms, Hormone-Dependent...) : These data suggest that prostate cancer cell motility and altered androgen receptor activity attributed to relaxin may be mediated in part by Wnt11
Kharaishvili et al., Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2011 (Prostatic Neoplasms) : Recent evidence suggests that Wnt signaling regulates androgen activity in prostate cancer cells, enhances androgen receptor expression and promotes the growth of prostate cancer even after androgen ablation therapy